Our fair value estimate is $5.20, based on the Jan. 9, 2025, exchange rate of USD 1.03/EUR. Our fair value estimate implies price/earnings and enterprise value/EBITDA multiples of 18 and 9, ...
Healthcare leaders are keen to embrace AI, partly to keep pace with competitors and other industries, but, more importantly, to increase efficiency and improve patient experiences. However, only 77% ...
As part of Cellebrite’s ongoing commitment to best practices in board governance, specifically those related to the separation of duties between the CEO and board chair, Adam H. Clammer, Managing ...